Symptomatic Pneumonitis with Durvalumab After Concurrent Chemoradiotherapy in Unresectable Stage III Non-Small-Cell Lung Cancer

JTO Clinical and Research Reports(2024)

Cited 0|Views22
No score
Key words
Immunotherapy,Radiotherapy,Durvalumab,Pulmonary toxicity,Locally advanced NSCLC
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined